IDEAS home Printed from https://ideas.repec.org/a/plo/pgph00/0001396.html
   My bibliography  Save this article

Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India

Author

Listed:
  • Dayoung Song
  • Sarah W Pallas
  • Rahul Shimpi
  • N Ramaswamy
  • Pradeep Haldar
  • Pauline Harvey
  • Pankaj Bhatnagar
  • Arun Katkar
  • Niniya Jayaprasad
  • Abhishek Kunwar
  • Sunil Bahl
  • Win Morgan
  • Raymond Hutubessy
  • Kashmira Date
  • Vittal Mogasale

Abstract

Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning.

Suggested Citation

  • Dayoung Song & Sarah W Pallas & Rahul Shimpi & N Ramaswamy & Pradeep Haldar & Pauline Harvey & Pankaj Bhatnagar & Arun Katkar & Niniya Jayaprasad & Abhishek Kunwar & Sunil Bahl & Win Morgan & Raymond , 2023. "Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India," PLOS Global Public Health, Public Library of Science, vol. 3(1), pages 1-11, January.
  • Handle: RePEc:plo:pgph00:0001396
    DOI: 10.1371/journal.pgph.0001396
    as

    Download full text from publisher

    File URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001396
    Download Restriction: no

    File URL: https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001396&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pgph.0001396?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. repec:plo:pntd00:0004616 is not listed on IDEAS
    Full references (including those not matched with items on IDEAS)

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pgph00:0001396. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: globalpubhealth (email available below). General contact details of provider: https://journals.plos.org/globalpublichealth .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.